Sort
53,477 grants matching “addiction”
Research Project 2 : Sweet and Cooling Flavors and Nicotine: Examinations in New and Established Tobacco Product Users
$676,639Suchitra Krishnan-Sarin · Yale University · U54 · FY2020 · DA
Teen Mothersâ Prenatal Cannabis Use and Co-Use with Tobacco
$676,607Natacha De Genna · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · DA
Evaluating the impact of fentanyl test strip use among rural and urban populations
$676,601Nichole L Michaels · Research Inst Nationwide Children'S Hosp · R01 · FY2023 · DA
Addressing Alcohol Use Related Health Disparities: A Hybrid Effectiveness Implementation Study of a Culturally Adapted MI for Latinx Alcohol and Drug Users
$676,503Christina S Lee · Boston University (Charles River Campus) · R01 · FY2020 · AA
Addressing Alcohol Use Related Health Disparities: A Hybrid Effectiveness Implementation Study of a Culturally Adapted MI for Latinx Alcohol and Drug Users
$676,486Christina S Lee · Boston University (Charles River Campus) · R01 · FY2023 · AA
Addressing Alcohol Use Related Health Disparities: A Hybrid Effectiveness Implementation Study of a Culturally Adapted MI for Latinx Alcohol and Drug Users
$676,486Christina S Lee · Boston University (Charles River Campus) · R01 · FY2024 · AA
Project 3: Informing and Correcting Perceptions Regarding Tobacco Produ p231-274
$676,457Cheryl Lee Perry · University Of Texas Hlth Sci Ctr Houston · P50 · FY2015 · CA
Molecular mechanisms of bacterial homologs of neurotransmitter:sodium symporters
$676,431Jonathan A Javitch · Columbia University Health Sciences · R01 · FY2009 · DA
Harnessing telemedicine to improve alcohol use disorder outcomes in primary care patients
$676,414Lewei Allison Lin · University Of Michigan At Ann Arbor · R01 · FY2023 · AA
Making Better Decisions: Policy Modeling for AIDS and Drug Abuse
$676,405Douglas K Owens · Stanford University · R37 · FY2022 · DA
Neural mechanisms of flexible visual-oculomotor decision rules
$676,402Long Ding · University Of Pennsylvania · R01 · FY2024 · EY
Examining opioid use disorder treatment in Medicaid managed care plans: policies and outcomes
$676,397Maureen T Stewart · Brandeis University · R01 · FY2023 · DA
Potent and Highly Selective D3 Ligands for the Treatment of Cocaine Abuse
$676,318Shaomeng Wang · University Of Michigan At Ann Arbor · R01 · FY2012 · DA
Signal Transduction by Tyrosine Phosphorylation
$676,298Tony R. Hunter · Salk Institute For Biological Studies · R01 · FY2011 · CA
E-cigarettes: deposition, absorption and brain accumulation of nicotine
$676,267Alexey G Mukhin · Duke University · R01 · FY2017 · DA
RCT of an Integrated Treatment of Persons with Co-Occurring HCV and Alcohol Abuse
$676,263Rae Jean Elizabeth Proeschold-Bell · Duke University · R01 · FY2014 · AA
Impact of Reduced Cannabis Use on Functional Outcomes
$676,208Nathan A. Kimbrel · Duke University · R33 · FY2021 · DA
Leveraging virtual care strategies to improve access and treatment for individuals with alcohol use disorders
$676,207Erin E. Bonar · University Of Michigan At Ann Arbor · R01 · FY2025 · AA
Genetics of oxycodone intake in a hybrid rat diversity panel.
$676,136Burt M Sharp · University Of Tennessee Health Sci Ctr · U01 · FY2021 · DA
Structure-based discovery of dopamine D1 receptor selective small molecule ligands
$676,062Bingfa Sun · Confometrx, Inc. · R44 · FY2019 · MH
Structure-based discovery of dopamine D1 receptor selective small molecule ligands
$676,062Bingfa Sun · Confometrx, Inc. · R44 · FY2020 · MH
Structure-based discovery of dopamine D1 receptor selective small molecule ligands
$676,062Bingfa Sun · Confometrx, Inc. · R44 · FY2021 · MH
Couples-Based HIV/STI Prevention for Injecting Drug Users in Kazakhstan
$676,058Nabila El-Bassel · Columbia Univ New York Morningside · R01 · FY2008 · DA
Trial of Integrated Smoking Cessation, Exercise, and Weight Management in SMI
$675,958Gail L Daumit · Johns Hopkins University · R01 · FY2015 · MH
Validation of Fibroblast-Derived PI16 as a Novel Target for pain Treatment
$675,862Andrew John Shepherd · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · NS